222 related articles for article (PubMed ID: 1897375)
1. Cholinergic strategies in the treatment of Alzheimer's disease.
Davidson M; Stern RG; Bierer LM; Horvath TB; Zemishlani Z; Markofsky R; Mohs RC
Acta Psychiatr Scand Suppl; 1991; 366():47-51. PubMed ID: 1897375
[TBL] [Abstract][Full Text] [Related]
2. Manipulation of the cholinergic system.
Geroldi C; Bianchetti A; Trabucchi M
Funct Neurol; 1997; 12(3-4):187-91. PubMed ID: 9218975
[No Abstract] [Full Text] [Related]
3. [Cholinergic treatment strategies in Alzheimer's disease].
Kurz A; Rüster P; Romero B; Zimmer R
Nervenarzt; 1986 Oct; 57(10):558-69. PubMed ID: 3785472
[No Abstract] [Full Text] [Related]
4. Treatment of Alzheimer's disease: an evaluation of the cholinergic approach.
Lemière J; Van Gool D; Dom R
Acta Neurol Belg; 1999 Jun; 99(2):96-106. PubMed ID: 10427352
[TBL] [Abstract][Full Text] [Related]
5. Strategies that support declining cholinergic neurotransmission in Alzheimer's disease patients.
Sirviö J
Gerontology; 1999; 45 Suppl 1():3-14. PubMed ID: 9876213
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic drugs, affective disorders and dementia: problems of clinical research.
Spiegel R
Acta Psychiatr Scand Suppl; 1991; 366():66-9. PubMed ID: 1897378
[No Abstract] [Full Text] [Related]
7. What is the rationale for new treatment strategies in Alzheimer's disease?
Rogawski MA
CNS Spectr; 2004 Jul; 9(7 Suppl 5):6-12. PubMed ID: 15241294
[TBL] [Abstract][Full Text] [Related]
8. The cholinergic hypothesis: a historical overview, current perspective, and future directions.
Bartus RT; Dean RL; Pontecorvo MJ; Flicker C
Ann N Y Acad Sci; 1985; 444():332-58. PubMed ID: 2990293
[No Abstract] [Full Text] [Related]
9. Biochemical pathology and treatment strategies in Alzheimer's disease: emphasis on the cholinergic system.
Winblad B; Messamore E; O'Neill C; Cowburn R
Acta Neurol Scand Suppl; 1993; 149():4-6. PubMed ID: 8128837
[TBL] [Abstract][Full Text] [Related]
10. The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach.
Davidson M; Stern RG
Psychiatr Clin North Am; 1991 Jun; 14(2):461-82. PubMed ID: 2062728
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Alzheimer's disease with cholinergic drugs.
Kumar V; Calache M
Int J Clin Pharmacol Ther Toxicol; 1991 Jan; 29(1):23-37. PubMed ID: 2004862
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's dementia: recent developments in cholinergic pharmacology.
Moss DE; Rodriguez LA
Tex Med; 1987 Jan; 83(1):32-4. PubMed ID: 3824230
[No Abstract] [Full Text] [Related]
13. Alzheimer's disease and anaesthesia: implications for the central cholinergic system.
Fodale V; Quattrone D; Trecroci C; Caminiti V; Santamaria LB
Br J Anaesth; 2006 Oct; 97(4):445-52. PubMed ID: 16950812
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic neuropharmacology: an update.
Palacios JM; Boddeke HW; Pombo-Villar E
Acta Psychiatr Scand Suppl; 1991; 366():27-33. PubMed ID: 1654727
[TBL] [Abstract][Full Text] [Related]
15. [Galantamine: a novel cholinergic agent for Alzheimer's disease].
Olazarán J; García G
Neurologia; 2002 Oct; 17(8):429-36. PubMed ID: 12396973
[TBL] [Abstract][Full Text] [Related]
16. The cerebrovascular role of the cholinergic neural system in Alzheimer's disease.
Van Beek AH; Claassen JA
Behav Brain Res; 2011 Aug; 221(2):537-42. PubMed ID: 20060023
[TBL] [Abstract][Full Text] [Related]
17. Cholinergic therapies for Alzheimer's disease: progress and prospects.
Palmer AM
Curr Opin Investig Drugs; 2003 Jul; 4(7):820-5. PubMed ID: 14619403
[TBL] [Abstract][Full Text] [Related]
18. Effect of cholinesterase inhibitors on attention.
Pepeu G; Giovannini MG; Bracco L
Chem Biol Interact; 2013 Mar; 203(1):361-4. PubMed ID: 23047023
[TBL] [Abstract][Full Text] [Related]
19. Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease.
Rombouts SA; Barkhof F; Van Meel CS; Scheltens P
J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):665-71. PubMed ID: 12438467
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic cholinergic agonists: pharmacological and clinical perspectives.
Palacios JM; Spiegel R
Prog Brain Res; 1986; 70():485-98. PubMed ID: 3554361
[No Abstract] [Full Text] [Related]
[Next] [New Search]
